Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study

Background. sequential chemotherapy can maintain dose intensity and preclude cumulative toxicity by increasing drug diversity. Purpose. to investigate the toxicity and efficacy of the sequential regimen of gemcitabine followed by paclitaxel in first line advanced stage non-small cell lung cancer (NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Surmont, V., Aerts, J. G. J. V., Tan, K. Y., Schramel, F., Vernhout, R., Hoogsteden, H. C., van Klaveren, R. J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777239/
https://www.ncbi.nlm.nih.gov/pubmed/19920864
http://dx.doi.org/10.1155/2009/457418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777239/
https://www.ncbi.nlm.nih.gov/pubmed/19920864
http://dx.doi.org/10.1155/2009/457418

Ejemplares similares